10x Science
The AI-native platform for next-generation protein characterization.
Our mission at 10x Science is to enable biopharmaceutical development to keep pace with AI-powered drug discovery.
Thanks to AI, the front end of drug discovery is flooding the pipeline with new drug candidates. However, current solutions for drug development are unable to resolve drug complexity and cannot keep up with modern demand. Our platform is the unlock for this bottleneck.
By applying modern AI to the development stage, specifically to protein characterization and quality assessment, we provide an end-to-end solution to dramatically speed up and scale up the preparation of candidates for the clinic.
Our team is composed of Stanford University researchers from a Nobel Laureate's lab with 18+ years of collective domain expertise, 47+ scientific publications, and a 2x YC Founder. We move at the highest velocity and are positioned to lead the next-generation of modern AI drug development.
Active Founders
Founder and CEO
Chemistry postdoc and Damon Runyon Cancer Research Fellow in Prof. Carolyn Bertozzi's lab (2022 Nobel Prize in Chemistry) at Stanford University. Next-generation scientific leader in chemical biology and glycobiology with 1390+ citations & h-index 20 (https://scholar.google.com/citations?user=nn7CGXgAAAAJ&hl=en). Received my B.S. double major in chemistry & mathematics at UC San Diego (2016) and Ph.D. in materials chemistry & analytical chemistry at the University of Wisconsin-Madison (2023).
Chemistry postdoc and Damon Runyon Cancer Research Fellow in Prof. Carolyn Bertozzi's lab (2022 Nobel Prize in Chemistry) at Stanford University. Next-generation scientific leader in chemical biology and glycobiology with 1390+ citations & h-index 20 (https://scholar.google.com/citations?user=nn7CGXgAAAAJ&hl=en). Received my B.S. double major in chemistry & mathematics at UC San Diego (2016) and Ph.D. in materials chemistry & analytical chemistry at the University of Wisconsin-Madison (2023).
Founder and COO
Previously received my B.S. in Biology from UNC-Chapel Hill. I then joined Dr. Steven Carr’s Proteomics Platform Lab at the Broad Institute of MIT and Harvard, where I developed new methods in mass spectrometry. I later became a Ph.D. student and NSF-GRFP fellow in the Department of Biology at Stanford University, where I was co-advised by Dr. Carolyn Bertozzi (2022 Nobel Laureate in Chemistry) and Dr. Or Gozani.
Previously received my B.S. in Biology from UNC-Chapel Hill. I then joined Dr. Steven Carr’s Proteomics Platform Lab at the Broad Institute of MIT and Harvard, where I developed new methods in mass spectrometry. I later became a Ph.D. student and NSF-GRFP fellow in the Department of Biology at Stanford University, where I was co-advised by Dr. Carolyn Bertozzi (2022 Nobel Laureate in Chemistry) and Dr. Or Gozani.
Founder and CTO
I am a 2x YC Founder. Previously, I built AI for go-to-market teams as the 2nd hire and founding engineer at Nooks. Then, I forward deployed myself in research labs at the University of Washington, UCSF, and Stanford, where I was mentored by world-renowned scientists in analytical chemistry and cancer research. In < 1 year, I published 2 papers and won 4 national awards. Now, I'm building ultrafast AI models for drug discovery teams to characterize proteins and pharmaceutical candidates.
I am a 2x YC Founder. Previously, I built AI for go-to-market teams as the 2nd hire and founding engineer at Nooks. Then, I forward deployed myself in research labs at the University of Washington, UCSF, and Stanford, where I was mentored by world-renowned scientists in analytical chemistry and cancer research. In < 1 year, I published 2 papers and won 4 national awards. Now, I'm building ultrafast AI models for drug discovery teams to characterize proteins and pharmaceutical candidates.
